Reduced phosphorylation of MLC2v has been implicated in human heart disease where phosphorylation was reduced to ~18% of total MLC2v in failing hearts from ~30%–40% in healthy hearts (Velden et al., 2003). This evidence concerns the gene MYL2 and heart disorder.